OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

This study has been completed.

Study NCT00040183 Information provided by OSI Pharmaceuticals

First Received: June 21, 2002 Last Updated: January 25, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	September 2004
Estimated Primary Completion Date:	No date given